Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening

High Throughput ◽

In Silico ◽

Naturally Occurring Homoisoflavonoids Function as Potent Protein Tyrosine Kinase Inhibitors by c-Src-Based High-Throughput Screening

Journal of Medicinal Chemistry ◽

10.1021/jm701501x ◽

2008 ◽

Vol 51 (15) ◽

pp. 4419-4429 ◽

Cited By ~ 56

Author(s):

Li-Gen Lin ◽

Hua Xie ◽

Hong-Lin Li ◽

Lin-Jiang Tong ◽

Chun-Ping Tang ◽

...

Keyword(s):

Tyrosine Kinase ◽

High Throughput ◽

Protein Tyrosine Kinase ◽

Kinase Inhibitors ◽

Protein Tyrosine ◽

Naturally Occurring

HIGH-THROUGHPUT SCREENING OF GLIOMA STEM CELL LINES FOR DRUG STRUCTURE- AND GENOTYPE-CORRELATED SENSITIVITY TO A PANEL OF TYROSINE KINASE INHIBITORS

Neuro-Oncology ◽

10.1093/neuonc/nou208.36 ◽

2014 ◽

Vol 16 (suppl 3) ◽

pp. iii32-iii32

Author(s):

J. de Groot ◽

C. Thomas ◽

Y. Piao ◽

N. Nguyen ◽

D. Drewry ◽

...

Keyword(s):

Stem Cell ◽

Tyrosine Kinase ◽

Cell Lines ◽

High Throughput ◽

Kinase Inhibitors ◽

Glioma Stem Cell ◽

Stem Cell Lines

High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors

Human Molecular Genetics ◽

10.1093/hmg/ddx323 ◽

2017 ◽

Vol 26 (22) ◽

pp. 4375-4387 ◽

Cited By ~ 10

Author(s):

Pedro P Cunha ◽

Pedro M Costa ◽

Catarina M Morais ◽

Inês R Lopes ◽

Ana M Cardoso ◽

...

Keyword(s):

Tyrosine Kinase ◽

High Throughput ◽

Kinase Inhibitors ◽

Glioblastoma Cell

In silico structural anatomization of spleen tyrosine kinase inhibitors: Pharmacophore modeling, 3D QSAR analysis and molecular docking studies

Journal of Molecular Structure ◽

10.1016/j.molstruc.2019.04.009 ◽

2019 ◽

Vol 1189 ◽

pp. 102-111 ◽

Cited By ~ 4

Author(s):

Ananta Ganjoo ◽

Chetti Prabhakar

Keyword(s):

Molecular Docking ◽

Tyrosine Kinase ◽

In Silico ◽

Kinase Inhibitors ◽

3D Qsar ◽

Pharmacophore Modeling ◽

Docking Studies ◽

Spleen Tyrosine Kinase ◽

Qsar Analysis

Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors

European Journal of Medicinal Chemistry ◽

10.1016/j.ejmech.2008.07.002 ◽

2009 ◽

Vol 44 (3) ◽

pp. 990-1000 ◽

Cited By ~ 36

Author(s):

Cristina Tintori ◽

Matteo Magnani ◽

Silvia Schenone ◽

Maurizio Botta

Keyword(s):

Tyrosine Kinase ◽

In Silico ◽

Kinase Inhibitors ◽

3D Qsar ◽

Src Tyrosine Kinase ◽

Qsar Studies ◽

Adme Prediction ◽

In Silico Adme Prediction

In vitro and in silico evaluation of EGFR targeting activities of curcumin and its derivatives

Food & Function ◽

10.1039/d1fo02002a ◽

2021 ◽

Author(s):

Yuan Liang ◽

Jingqi Zhao ◽

Haoyang Zou ◽

Jie Zhang ◽

Tiehua Zhang

Keyword(s):

Tyrosine Kinase ◽

In Silico ◽

Curcumin and its derivatives are potential tyrosine kinase inhibitors that target EGFR.

Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK—HER2 and VEGFR2 receptors, by in silico approach

Molecular Diversity ◽

10.1007/s11030-021-10304-5 ◽

2021 ◽

Author(s):

Dipayan Paul ◽

Saurov Mahanta ◽

Hui Tag ◽

Sanjib Kumar Das ◽

Debmalya Das Gupta ◽

...

Keyword(s):

Tyrosine Kinase ◽

In Silico ◽

High-throughput colorimetric detection of tyrosine kinase inhibitors based on the aggregation of gold nanoparticles

Analytical Biochemistry ◽

10.1016/j.ab.2007.08.032 ◽

2008 ◽

Vol 373 (1) ◽

pp. 161-163 ◽

Cited By ~ 21

Author(s):

Jun Oishi ◽

Xiaoming Han ◽

Jeong-Hun Kang ◽

Yoji Asami ◽

Takeshi Mori ◽

...

Keyword(s):

Gold Nanoparticles ◽

Tyrosine Kinase ◽

High Throughput ◽

Kinase Inhibitors ◽

Colorimetric Detection

High throughput routine determination of 17 tyrosine kinase inhibitors by LC–MS/MS

Journal of Pharmaceutical and Biomedical Analysis ◽

10.1016/j.jpba.2017.11.060 ◽

2018 ◽

Vol 150 ◽

pp. 112-120 ◽

Cited By ~ 30

Author(s):

Camille Merienne ◽

Marine Rousset ◽

Dominique Ducint ◽

Nadège Castaing ◽

Karine Titier ◽

...

Keyword(s):

Tyrosine Kinase ◽

High Throughput ◽

Discovery of potent antiproliferative agents from selected oxygen heterocycles as EGFR tyrosine kinase inhibitors from the U.S. National Cancer Institute database by in silico screening and bioactivity evaluation

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/j.bmcl.2021.128524 ◽

2022 ◽

pp. 128524

Author(s):

Nattanan Jiwacharoenchai ◽

Rungroj Saruengkhanphasit ◽

Worawat Niwetmarin ◽

Supaporn Seetaha ◽

Kiattawee Choowongkomon ◽

...

Keyword(s):

Tyrosine Kinase ◽

National Cancer Institute ◽

In Silico ◽

Kinase Inhibitors ◽

In Silico Screening ◽

Antiproliferative Agents ◽

Oxygen Heterocycles ◽

Egfr Tyrosine Kinase Inhibitors ◽

The U.S